Publikationen in Zusammenarbeit mit Forschern von Universidad de Salamanca (6)

2016

  1. Effect of mTORC1/mTORC2 inhibition on T cell function: Potential role in graft-versus-host disease control

    British Journal of Haematology, Vol. 173, Núm. 5, pp. 754-768

  2. Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development

    Journal of Hematology and Oncology, Vol. 9, Núm. 1

2009

  1. Prolonged idiotypic vaccination against follicular lymphoma

    Leukemia and Lymphoma, Vol. 50, Núm. 1, pp. 47-53

2006

  1. Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma

    Journal of the National Cancer Institute, Vol. 98, Núm. 18, pp. 1292-1301

  2. Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation

    Leukemia and Lymphoma, Vol. 47, Núm. 1, pp. 29-37

2004

  1. Imatinib Inhibits Proliferation of Ewing Tumor Cells Mediated by the Stem Cell Factor/KIT Receptor Pathway, and Sensitizes Cells to Vincristine and Doxorubicin-Induced Apoptosis

    Clinical Cancer Research, Vol. 10, Núm. 2, pp. 751-761